Back to Selection     Print       Date : 31 May 2025
Fund Summary
UTI Healthcare Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 28-Jun-1999
Corpus(Cr.) 1062.0 Latest NAV 287.2834 As on 10-07-2025
Equity(%) 97.34 52 Week High 295.297
Debt(%) 2.66 52 Week Low 245.497
Others(%) 0.0 Exit Load 1% for redemption within 30 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 2.27
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Kamal Gada
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 29.05%
Top 10 Holdings 46.10%
Top 25 Holdings 81.58%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 71.83
Healthcare 24.45
Cash 2.65
Communication 1.06
Others 0.01
 
 
 
 
 
Portfolio Metrics
PB Ratio 5.66
PE Ratio 33.66
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 10.44
Cipla Limited 5.52
Dr Reddys Laboratories Limited 4.66
Procter & Gamble Health Limited 4.34
Ajanta Pharma Limited 4.09
Glenmark Pharmaceuticals Limited 3.78
Apollo Hospitals Enterprise Limited 3.65
DIVI LABORATORIES LTD 3.49
Fortis Health Care Ltd 3.09
Eris Lifesciences Limited 3.04
EQ- JUPITER LIFE LINE HOSPITALS LTD 2.95
Krishna Inst of Medical Sciences Ltd. 2.77
Aurobindo Pharma Limited 2.70
Gland Pharma Limited 2.69
Max Healthcare Institute Limited 2.67
NET CURRENT ASSETS 2.65
Cohance Lifesciences Limited 2.65
Lupin Limited 2.58
Caplin Point Laboratories Limited 2.53
IPCA Laboratories Limited 2.06
Aster DM Healthcare Limited 2.03
Alkem Laboratories Limited 1.92
Zydus Lifesciences Limited 1.91
EQ- GLOBAL HEALTH LTD. 1.73
Pfizer Limited 1.64

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
1.88% 12.99% 0.76% 16.38%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.22% 13.80% 9.05% 5.49%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
31.84% 26.04% 21.93% 11.54%
 
 
15.83% 17.36% 20.09% 13.10%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
UTI Healthcare Fund (G) 15.78% -0.6627 14.7120% 47.1545 -0.0331
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
UTI Healthcare Fund (G) -12.4772% 0.7528 -0.1697 15.3925 -1.1300
 
Back to Selection